Back to CRSP overview

CRSP CRISPR Therapeutics AG PE ratio, current and historical analysis

The current PE ratio of CRSP can't be determined, as the TTM EPS of -$2.69 is negative. The last PE ratio of CRISPR Therapeutics AG, recorded in March 2022, was 15.16.

CRSP PE ratio history

How has CRSP's PE ratio performed in the past

The PE ratio of CRISPR Therapeutics AG has averaged 34.33 over the last seven years. In the past seven years, CRSP's PE ratio peaked in the Jun 2020 quarter at 118.53, when the stock price was $73.49 and the EPS was $0.62. The lowest point was in the Sep 2017 quarter, when it reached 4.68 with a price of $17.87 and an EPS of $3.82.

Average
34.33
Median
21.08
Minimum
4.68
Maximum
118.53

CRISPR Therapeutics AG PE ratio by year

Year PE ratio Change
2023 N/A N/A
2022 N/A N/A
2021 15.25 N/A
2020 N/A N/A
2019 49.52 N/A
2018 N/A N/A
2017 N/A N/A
2016 N/A N/A
2015 N/A N/A
2014 N/A N/A

CRSP average PE ratio chart

What is the average PE ratio of CRSP for the past years
3-year avg
N/A
5-year avg
42.11
10-year avg
N/A
15-year avg
N/A

CRSP PE vs peers

What is CRSP's PE ratio compared to its peers
Stock name PE ratio Market cap
OCUL Ocular Therapeutix Inc N/A $850.34M
OCX OncoCyte Corp N/A $35.95M
OGEN Oragenics Inc N/A $6.86M
CRSP CRISPR Therapeutics AG N/A $5.14B

Frequently asked questions

What is CRISPR Therapeutics AG's PE ratio?

The current price to earnings ratio of CRSP can't be calculated, as its EPS of -$2.69 is negative.

What is the 5-year average PE ratio for CRISPR Therapeutics AG (CRSP)?

Over the last 5 years, the average price to earnings ratio for CRSP stock is 42.11.

What is the highest PE ratio for CRSP?

In the last seven years, the Jun 2020 quarter recorded the highest quarterly PE ratio at 118.53.

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.